Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Legislation
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
2022 Savings Report
2022 Interactive State Savings Map
2022 Voices of Access Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
Interactive Savings Map
- Find out how much your state saved from generic and biosimilar medicines.
Learn More
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Releases
Share
Press Release
Oct 3, 2022
| Susan Reilly
AAM Statement on the Centers for Medicare & Medicaid Services’ Implementation of Medicare Part B Payment Changes for Biosimilars
Press Release
Sep 21, 2022
| Susan Reilly
Generic and Biosimilar Drugs Generate A Record $373 Billion For America’s Patients and Healthcare System in 2021
Press Release
Sep 15, 2022
| Susan Reilly
AAM Statement: New Study Shows Formulary Abuses Force Patients to Pay More for Generic Drugs Even as the Prices of Those Drugs Go Down
Press Release
Aug 7, 2022
| Allen Goldberg
AAM Statement on Senate Passage of Inflation Reduction Act
Press Release
Jul 28, 2022
| Allen Goldberg
Association for Accessible Medicines (AAM) Elevates David Gaugh to Executive Vice President for Sciences & Regulatory Affairs
Press Release
Jul 6, 2022
| Allen Goldberg
AAM Statement on BBB 2.0
Press Release
Jun 6, 2022
| Allen Goldberg
Giuseppe Randazzo Joins AAM as Vice President, Sciences and Regulatory Affairs
Press Release
May 23, 2022
| Allen Goldberg
AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices
Press Release
May 16, 2022
| Allen Goldberg
Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council
Press Release
May 11, 2022
| Allen Goldberg
AAM Statement on House Energy and Commerce Health Subcommittee Markup of H.R. 7667 Reauthorizing Generic Drug and Biosimilar User Fee Amendments
Press Release
Apr 1, 2022
| Rachel Schwartz
HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries
Press Release
Feb 15, 2022
| Rachel Schwartz
AAM Statement on the Confirmation of Robert Califf to Lead FDA
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Legislation
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
2022 Savings Report
2022 Interactive State Savings Map
2022 Voices of Access Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action